AML BIOTECH PARTNERS

AML Biotech Partners

#Financial #More

AML BIOTECH PARTNERS

Status:
Active


Investments List

Date Company Article Money raised
2018-07-12 Nohla Therapeutics AML Biotech Partners investment in Series B - Nohla Therapeutics 11 M USD
2018-05-15 Nohla Therapeutics AML Biotech Partners investment in Series B - Nohla Therapeutics 45 M USD

More informations about "AML Biotech Partners"

AML Biotech Partners - Investments, Portfolio & Company Exits

AML Biotech Partners has made 2 investments. Their most recent investment was on Jul 12, 2018, when Nohla Therapeutics raised $11M.See details»

AML Biotech Partners - Updates, News, Events, Signals & Triggers

Recent News & Activity Edit Recent News & Activity Section Funding Roundโ€ขJul 12, 2018 Nohla Therapeutics raised $11,000,000 / Series B from 5AM Ventures and 8 other investors โ€ฆSee details»

AML Biotech Partners I LLC - Company Profile and News

Company profile page for AML Biotech Partners I LLC including stock price, company news, executives, board members, and contact informationSee details»

AML Biotech Partners - Unicorn Nest

The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the AML Biotech Partners, startups are often financed by ARCH Venture Partners, 5AM Ventures, The Jagen โ€ฆSee details»

AML Biotech Partners Investment Information | CipherBio

Find out which companies AML Biotech Partners is investing in, as well as the disease indication and therapeutic approach of every investment!See details»

AML BIOTECH PARTNERS I, LLC in Wilmington, DE - Bizapedia

Sep 4, 2024 Discover Company Info on AML BIOTECH PARTNERS I, LLC in Wilmington, DE, such as Contacts, Addresses, Reviews, and Registered Agent.See details»

AML Biotech Partners - Web3 Crypto Company Profile, Funding, โ€ฆ

AML Biotech Partners has made 2 investments. Their most recent investment was on Jul 12, 2018, when Nohla Therapeutics raised $11M.See details»

AML Biotech Partners - BioCentury Company Profiles - BCIQ

AML Biotech Partners - BioCentury Company Profiles for the biopharma industrySee details»

AML BIOTECH PARTNERS III, LLC in Wilmington, DE | Company โ€ฆ

Sep 19, 2024 Discover Company Info on AML BIOTECH PARTNERS III, LLC in Wilmington, DE, such as Contacts, Addresses, Reviews, and Registered Agent.See details»

AML Biotech Partners Venture Capital Profile | VentureDeal

Start your Free 14 Day Trial now โ€“ no obligation or credit card required.See details»

HOME - Legend Biotech

Nov 7, 2024 Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver โ€ฆSee details»

AML Biotech Partners - Crunchbase

3AM 3AM AML Biotech Partners and 3AM share similar descriptions These companies are similarSee details»

AML Biotech Partners-ๅŠจ่„‰็ฝ‘ - vbdata.cn

ๅ…จ็ƒไบงไธš้“พๆŽฅๅนณๅฐ ้‡ๅบ†ๅธ‚ๆธๅŒ—ๅŒบ้‡‘ๆ˜Ÿ็ง‘ๆŠ€ๅคงๅŽฆAๅŒบ5ๆฅผ512ๅฎค ่”็ณป็”ต่ฏ๏ผš023-67685030๏ผˆ้‡ๅบ†๏ผ‰See details»

AML Biotech Partners-ๅŠจ่„‰็ฝ‘ๆ•ฐๆฎ

Nohla Therapeutics ๆ–ฐๅž‹็ป†่ƒž็–—ๆณ•็ ”ๅ‘ๅ•† ็”Ÿ็‰ฉ็ง‘ๆŠ€ 2018-05-16 B่ฝฎ 4500ไธ‡็พŽๅ…ƒ CelgeneARCH Venture PartnersFidelity Investments5AM VenturesAML Biotech PartnersAlexandria Venture โ€ฆSee details»

Novotech Publishes Research Report On Acute Myeloid โ€ฆ

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at โ€ฆSee details»

Actinium Pharmaceuticals, Inc. (ATNM)

Targeted Radiotherapies for Patients with Unmet Needs Actinium is developing a pipeline of Antibody Radiation Conjugates for targeted conditioning and combination ...See details»

Moleculin Biotech Advances Annamycin in AML Treatment

Jan 27, 2025 Moleculin Biotech updates on Annamycin's clinical trial progress for AML, highlighting CEO Walter Klemp's insights into the treatment landscape.See details»

Moleculin biotech highlights pivotal Phase 3 trials for Annamycin โ€ฆ

1 day ago Discover how Moleculin Biotech advances Annamycin's Phase 3 trial for AML treatment, with key milestones planned through 2025.See details»

Legend Biotech Company Profile - Office Locations, Competitors

Oct 29, 2024 Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications. It also provides research and โ€ฆSee details»

Vistara Bioscience - Crunchbase Company Profile & Funding

The networks serve as biomarker panels to follow along the drug discovery process and may suggest combinatorial targets or new ones. Vistara offers its services to pharma and biotech โ€ฆSee details»